sphingosine/рак

Линкът е запазен в клипборда

Изберете тип сортиране

11 резултата

Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Liver resection is an effective treatment for both benign and malignant liver diseases. However, post-hepatectomy liver failure (PHLF) is still a life-threatening complication of liver resection. The pathophysiological mechanism of PHLF has not yet been fully studied, and there is still a lack of

A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

This is an open-label clinical study to explore the activity signal of ABC294640 and of ABC294640 and HCQ in adult subjects who have been diagnosed with unresectable cholangiocarcinoma either intra- perhilar or extra-hepatic. The study will be conducted at 5 sites in the USA. For Part 1, a maximum

Vulvodynia: Identification of Potential Relevant Biomarkers

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Sphingosine-1-phosphate (S1P) is a potent anti-apoptotic sphingolipid with potent pro-inflammatory actions which are driven in most part by activation of the S1P receptor subtype S1PR158. Biologically active S1P is generated by the phosphorylation of sphingosine, catalyzed by two sphingosine kinases

Supervised Exercise in Improving Physical Fitness Before Surgery in Patients With Resectable Bone Cancer

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

PRIMARY OBJECTIVES: I. To determine if regular exercise, which may improve delivery and efficacy of chemotherapy, is feasible in children and young adults with malignant bone tumors undergoing neoadjuvant chemotherapy. SECONDARY OBJECTIVES: I. To determine if exercise results in a change in tumor

Serum Sphingolipidomic Analyses in Healthy, Diabetic and Prediabetic Subjects

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

The first purpose of this study is to determine whether serum sphingolipid metabolites associate significantly with the weight among type 2 diabetes. 60 patients with diagnosed type 2 diabetes will be recruited. The serum concentrations of sphingolipid metabolites of 20 type 2 diabetic patients with

ABC294640 in Refractory / Relapsed Multiple Myeloma

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Objectives for Phase 1b: Primary Objectives • To assess safety and determine the maximum tolerated dose (MTD) of single agent ABC294640 in patients with refractory or relapsed multiple myeloma (MM) who have been previously treated with proteasome inhibitors and immunomodulatory agents. Secondary

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Five evaluable patients with newly diagnosed high grade gliomas who will undergo standard concomitant radiation and temozolomide followed by adjuvant temozolomide will be accrued to this open-label, single arm, safety study. Oral fingolimod will be given 1 week prior to the initiation of concurrent

Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Sphingosine Kinase (SK) is an innovative target for anti-cancer therapy due to its critical role in lipid metabolism which drives cancer cell growth. We have found that the SK inhibitor ABC294640 (which is formulated for clinical use as an oral agent) significantly inhibits and reverses progression

ABC294640 in Treating Patients With Advanced Solid Tumors

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

PRIMARY OBJECTIVES: I. To assess safety and determine the maximum tolerated dose (MTD) and the dose limiting toxicities (DLT) of ABC294640 (sphingosine kinase-2 inhibitor ABC294640) in patients with solid organ tumors. (Part I) II. To assess the safety and tolerability of ABC294640 at the MTD in an

Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

ASONEP™ (sonepcizumab/LT1009) is a humanized monoclonal antibody that possesses anti-angiogenic and anti-tumor activity in animal models of human cancer. ASONEP™ binds sphingosine 1-phosphate (S1P), a bioactive lipid signaling molecule that possesses potent pro-growth effects. Preclinical studies

Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

OBJECTIVES: Primary - Determine the maximum tolerated dose (MTD) of bortezomib and celecoxib in patients with advanced solid tumors. Secondary - Determine the overall pattern of toxicities associated with this combination, including the emergence of any cumulative toxicities, during multiple courses

Присъединете се към нашата
страница във facebook

Herbal & Natural Medicine

Най-пълната база данни за лечебни билки, подкрепена от науката

Работи на 55 езика
Билкови лекове, подкрепени от науката
Разпознаване на билки по изображение
Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
Прочетете научни публикации, свързани с вашето търсене
Търсете лечебни билки по техните ефекти
Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания